Oncology Sponsored 12 Questions with Gerhard du Toit As Global Head of Oncology for IQVIA Biotech, Gerhard du Toit manages all aspects of oncology clinical trials, optimising strategies and enhancing delivery from early to late phases.
R&D Sponsored 12 Questions with Meg Hooton Meg Hooton, President of IQVIA Biotech, leads the organisation, providing clinical development solutions for biotech and emerging biopharma clients.
Sales & Marketing Sponsored 12 Questions with Rebecca Douglas Rebecca Douglas is a strategic leader with a passion for nurturing talent.
R&D Sponsored 12 Questions with Irina Spirieva Irina Spirieva started her career in fast-moving consumer goods working in brand management for AB-InBev and Heineken.
Sales & Marketing Sponsored 12 Questions with Dr James Burt James Burt, CEO of Pharmanovia, is a seasoned leader focused on driving innovation in the value-added medicines (VAMs) space.
Sales & Marketing Sponsored 12 Questions with Caroline Phillips Caroline Phillips is the Vice President of Medical Affairs at Medscape, with over 25 years of experience in the pharmaceutical industry.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends